By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > FQAL ETF: Not The Most Attractive Quality ETF (NYSEARCA:FQAL)
News

FQAL ETF: Not The Most Attractive Quality ETF (NYSEARCA:FQAL)

News
Last updated: 2023/12/29 at 12:40 AM
By News
Share
6 Min Read
SHARE

Contents
FQAL strategy and portfolioFundamentalsPerformanceFQAL vs. competitorsTakeaway

FQAL strategy and portfolio

Fidelity® Quality Factor ETF (NYSEARCA:FQAL) started investing operations on 9/12/2016 and tracks the Fidelity U.S. Quality Factor Index. It has a portfolio of 126 stocks, a dividend yield of 1.35% and a total expense ratio of 0.15%.

As described by Fidelity, the underlying index starts from the largest 1000 U.S. stocks based on market cap and uses a rules-based proprietary methodology focused on higher profitability, stable cash flows, and good balance sheets. The index is rebalanced twice a year, and sector weights are reset to be sector-neutral relative to the parent index. The portfolio turnover rate was 43% in the most recent fiscal year.

The fund is mostly invested in large and mega caps companies (about 73% of asset value). The heaviest sector is technology (28.5%), followed by financials (13.3%) and healthcare (13.2%). The sector breakdown is very close to the SPDR® S&P 500 ETF Trust (SPY), which is consistent with the sector-neutral methodology (even if the parent index includes 1000 stocks instead of 500).

FQAL sector breakdown

FQAL sector breakdown (Chart: author; data: Fidelity, SSGA)

The portfolio is quite concentrated: the top 10 companies, listed below, represent 31.7% of asset value. Microsoft and Apple weigh about 15% together. Risks related to other individual companies are low.

Ticker

Name

Weight (%)

EPS growth %TTM

P/E TTM

P/E fwd

Yield%

MSFT

Microsoft Corp.

7.54

11.28

36.23

33.33

0.80

AAPL

Apple, Inc.

7.39

0.45

31.51

29.56

0.50

GOOGL

Alphabet, Inc.

3.72

3.56

26.91

24.44

0

LLY

Eli Lilly & Co.

2.06

-18.63

107.34

88.05

0.89

TSLA

Tesla, Inc.

2.05

-4.04

84.19

85.32

0

UNH

UnitedHealth Group, Inc.

2.02

12.84

22.69

20.95

1.44

META

Meta Platforms, Inc.

1.97

7.92

31.59

24.92

0

V

Visa, Inc.

1.72

19.04

31.77

26.20

0.80

AVGO

Broadcom Inc.

1.71

25.65

34.19

23.97

1.86

ADBE

Adobe, Inc.

1.56

17.00

50.43

33.22

0

Fundamentals

FQAL is significantly more expensive than SPY, regarding the price/book and price/sales ratios, and cheaper in price/earnings. The aggregate earnings growth is superior to the benchmark.

FQAL

SPY

P/E TTM

20.88

22.64

Price/Book

5.6

4

Price/Sales

4.06

2.58

Price/Cash Flow

15.62

15.71

Earnings growth

20.07%

17.47%

Data: Fidelity.

In my ETF reviews, risky stocks are companies with at least 2 red flags among: bad Piotroski score, negative ROA, unsustainable payout ratio, bad or dubious Altman Z-score, excluding financials and real estate where these metrics are unreliable. With this assumption, 8 stocks out of 126 are risky and they weight 6.3% asset value, which is a good point.

According to the calculation of aggregate quality metrics reported in the next table, portfolio quality is significantly superior to the benchmark. The return on assets is especially impressive.

FQAL

SPY

Altman Z-score

7.01

3.62

Piotroski F-score

6.14

5.73

ROA % TTM

15.42

7.24

Performance

Since inception, FQAL has lagged the S&P 500 by 75 bps in annualized return. Risk measured in drawdown and price volatility is similar to the benchmark.

Total Return

Annual Return

Drawdown

Sharpe ratio

Volatility

FQAL

141.30%

12.88%

-33.71%

0.68

16.41%

S&P 500

153.17%

13.63%

-33.72%

0.71

16.66%

FQAL is on par with the S&P 500 in 2023:

FQAL vs S&P 500, year-to-date

FQAL vs S&P 500, year-to-date (Seeking Alpha)

FQAL vs. competitors

The next table compares characteristics of FQAL and the three largest U.S. quality ETFs:

  • iShares MSCI USA Quality Factor ETF (QUAL)
  • Invesco S&P 500 Quality ETF (SPHQ)
  • JPMorgan U.S. Quality Factor ETF (JQUA).

FQAL

QUAL

SPHQ

JQUA

Inception

9/12/2016

7/16/2013

12/6/2005

11/8/2017

Expense Ratio

0.15%

0.15%

0.15%

0.12%

AUM

$386.46M

$36.14B

$6.75B

$3.35B

Avg Daily Volume

$2.06M

$234.48M

$57.44M

$29.71M

Number of Holdings

133

130

102

249

Assets in Top 10

31.20%

37.09%

44.73%

19.47%

Div. Yield TTM

1.35%

1.16%

1.42%

1.19%

FQAL is by far the smallest (in assets) and less liquid (in dollar volume) of this group. The next chart compares total returns, starting on 11/13/2017 to match all inception dates. FQAL has lagged its competitors. The best performer is the JP Morgan fund JQUA.

FQAL vs competitors since 11/13/2017

FQAL vs competitors since 11/13/2017 (Seeking Alpha)

In 2023, FQAL is on par with SPHQ and JQUA, but behind QUAL:

FQAL vs competitors, year-to-date

FQAL vs competitors, year-to-date (Seeking Alpha)

Takeaway

Fidelity® Quality Factor ETF implements a sector-neutral quality strategy in a large cap universe. Holdings are selected by systematic rules based on profitability, stable cash flows and good balance sheets. As expected, quality metrics are superior to the benchmark, especially the return on assets. Nevertheless, FQAL has slightly lagged the S&P 500 Index since inception in September 2016. It has also lagged its three larger competitors for 6 years. The sector-neutral constraint has likely been a drag for the fund: JQUA and SPHQ, which are more flexible regarding sector weights, have performed better.

Read the full article here

News December 29, 2023 December 29, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

SMH: Semi Investors Appearing Greedy And Forgetful Again (Downgrade) (NASDAQ:SMH)

By News
News

Want To Potentially Crush The S&P 500? Then Consider These 2 ETFs

By News
News

Zeta: The Stock Is Too Cheap Amid M&A Interest (NYSE:ZETA)

By News
News

CoStar Group: Short-Term Pain With Long-Term Gain (NASDAQ:CSGP)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?